A groundbreaking study recently published in the New England Journal of Medicine has shown that a combination of two existing biologic drugs can stop the progression of multiple myeloma, a serious type of blood cancer.
Informatie preluata din publicatia „Bursa” – citeste integral articolul – click aici
